放射学实践2024,Vol.39Issue(2) :218-226.DOI:10.13609/j.cnki.1000-0313.2024.02.013

多方位MRI影像组学预测局部进展期直肠癌新辅助放化疗疗效

Multi-directional MRI radiomics to predict the efficacy of neoadjuvant chemoradiotherapy for locally ad-vanced rectal cancer

周晓俞 杨筠 刘学焕 包翠萍 董龙春 刘筠
放射学实践2024,Vol.39Issue(2) :218-226.DOI:10.13609/j.cnki.1000-0313.2024.02.013

多方位MRI影像组学预测局部进展期直肠癌新辅助放化疗疗效

Multi-directional MRI radiomics to predict the efficacy of neoadjuvant chemoradiotherapy for locally ad-vanced rectal cancer

周晓俞 1杨筠 2刘学焕 2包翠萍 2董龙春 2刘筠3
扫码查看

作者信息

  • 1. 224001 江苏,南京中医药大学附属盐城市中医院医学影像科
  • 2. 300122 天津,天津市人民医院影像中心
  • 3. 天津市第四中心医院,天津市人民医院转化学院
  • 折叠

摘要

目的:采用MRI影像组学方法,提取局部进展期直肠癌(LARC)病灶影像组学特征,并联合临床及常规影像特征构建预测模型,探讨模型对新辅助放化疗(nCRT)疗效的预测效能.方法:回顾性分析209例LARC患者nCRT前的临床及影像资料.LARC患者在nCRT后6~8周行全系膜切除术(TME),并评估肿瘤病理退缩分级(TRG).按疗效分为nCRT反应良好组(TRG0~1级)和反应不良组(TRG2~3级),按照1∶1随机分为训练组和验证组对模型进行内部验证.手动勾画T2WI序列横轴面(TRA)、矢状面(SAG)及冠状面(COR)图像提取影像组学特征,采用LASSO回归筛选特征并构建影像组学标签.通过多因素logistics分析筛选nCRT疗效的独立预测因子并构建联合预测模型,采用ROC曲线及校正曲线对模型进行评估,并使用临床决策曲线评价模型的临床价值.结果:209例患者中nCRT反应良好组61例,反应不良组148例.T2WI序列横轴面、矢状面、冠状面图像各提取379个影像组学特征,ICC为0.9的特征中TRA 96个,SAG 88个,COR 91个.LASSO回归筛选的特征中TRA 4个,SAG 5个,COR 2个,联合图像(COM)7个.TRA、SAG、COR、COM等四个影像组学标签模型预测nCRT疗效的AUC值分别为0.637、0.682、0.619、0.731.多因素logistics分析结果表明COM影像组学标签、升高的CEA(>3.4 ng/mL)和壁外血管侵犯(EMVI)是nCRT疗效的独立预测因子,联合三者构建的联合预测模型预测nCRT疗效的AUC值为0.811,模型得到了很好的内部验证,校准度较高,临床决策曲线显示了较高的临床应用价值.结论:联合T2WI序列横轴面、矢状面、冠状面图像构建的多方位影像组学标签可以在治疗前对LARC患者nCRT疗效进行预测,联合升高的CEA(>3.4 ngmL)、EMVI、COM影像组学标签等构建的模型,其预测效能进一步提高,可以辅助制定个体化诊疗方案,实现最大治疗收益.

Abstract

Objective:The radiomics features of locally advanced rectal cancer(LARC)lesions were extracted using the MRI radiomics method,and a prediction model was constructed by combining clinical and conventional imaging features to explore the predictive efficacy of the model on the efficacy of neoadjuvant chemoradiotherapy(nCRT).Methods:The clinical and imaging data of 209 LARC pa-tients before nCRT were retrospectively analyzed.Total mesorectal resection(TME)was performed on the patients with LARC 6~8 weeks after nCRT,and were assessed for tumor pathological regres-sion grading(TRG).According to the efficacy,the patients were divided into a group of good nCRT response(TRG0~1 grade)and a group of poor response(TRG2~3 grade).It were randomly divided into training and verification group in accordance with 1:1 for internal verification of the model.The radiomics features were extracted through mannually sketching the transverse,sagittal and coronal T2WI images.The features were screened by LASSO regression,and the radiomics labels were con-structed.Then,the independent predictors of the efficacy of nCRT were screened by multifactorial lo-gistic analysis to construct prediction model.The ROC curves and correction curves were used to eval-uate the model,and the clinical value of the model was evaluated by clinical decision curves.Results:A-mong 209 patients,61 had good nCRT response and 148 had poor nCRT response.A total of 379 ra-diomics features were extracted from each of the transverse,sagittal and coronal T2WI images.The features with ICC≥0.9:TRA:96,SAG:88,COR:91.LASSO regression screening features:TRA:4,SAG:5,COR:2,COM:7.The AUC values of TRA,SAG,COR and COM radiomics labels models in predicting the efficacy of nCRT were 0.637,0.682,0.619 and 0.731,respectively.The results of multi-variate logistic analysis showed that the COM radiomics labelling,elevated CEA level(>3.4ng/mL)and extra-mural vascular invasion(EMVI)were independent predictors of the efficacy of nCRT.The area of AUC cureve of prediction model was 0.811.The model was well validated internally,with high calibration,and the clinical decision curve showed high clinical application value.Conclusions:The multi-directional radiomics labels constructed by combining transverse,sagittal and coronal images form T2WI sequences can predict the efficacy of nCRT in LARC patients.The predictive efficacy of the model is further improved by combining the elevated CEA(>3.4ng/mL),EMVI and COM radiomics label,which can assist in formulating individualized diagnosis and treatment plans to achieve maximum benefits.

关键词

直肠肿瘤/局部进展期直肠癌/新辅助放化疗/影像组学/磁共振成像/疗效评估

Key words

Rectal tumor/Locally advanced rectal cancer/Neoadjuvant chemoradiation/Ra-diomics/Magnetic resonance imaging/Efficacy evaluation

引用本文复制引用

基金项目

国家自然科学基金面上项目(12174203)

天津市科技计划面上项目(21JCYBJC00120)

出版年

2024
放射学实践
华中科技大学同济医学院

放射学实践

CSTPCD北大核心
影响因子:1.08
ISSN:1000-0313
参考文献量33
段落导航相关论文